MARKET

RANI

RANI

Rani Therapeutics Holdings, Inc.
NASDAQ
0.7665
+0.0068
+0.90%
Opening 10:06 06/17 EDT
OPEN
0.7501
PREV CLOSE
0.7597
HIGH
0.7890
LOW
0.7501
VOLUME
68.76K
TURNOVER
--
52 WEEK HIGH
3.870
52 WEEK LOW
0.3870
MARKET CAP
104.44M
P/E (TTM)
-1.8773
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RANI last week (0608-0612)?
Weekly Report · 2d ago
Weekly Report: what happened at RANI last week (0601-0605)?
Weekly Report · 06/08 10:35
Weekly Report: what happened at RANI last week (0525-0529)?
Weekly Report · 06/01 10:41
Rani Therapeutics Rated Buy as Analyst Highlights RT-114 Progress, Chugai Partnership and Cash Runway; $11 Price Target Reiterated
TipRanks · 06/01 10:15
Rani Therapeutics Shareholders Back Board and Auditor at Meeting
TipRanks · 05/29 11:42
Rani Therapeutics stockholders elect directors at annual meeting
PUBT · 05/29 10:04
Rani Therapeutics Announces $20 Million Equity Financing
TipRanks · 05/27 10:39
Rani Announces Pricing Of $20 Mln Direct Offering At $1.07 Per Share; Stock Down
NASDAQ · 05/26 15:46
More
About RANI
Rani Therapeutics Holdings, Inc. is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. The Company has developed the RaniPill capsule, which is a proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. The RaniPill capsule is designed to deliver a variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. It has two configurations of the platform: the RaniPill GO and the RaniPill HC. The RaniPill GO is designed to deliver up to a 3 mg dose of drug in microtablet form with high bioavailability. It is also developing a high-capacity version of the RaniPill capsule known as the RaniPill HC. Its product candidate pipeline includes obesity programs (RT-114 and RT-116), immunology programs (RT-105 and RT-111) and endocrinology programs (RT-102 and RT-110).

Webull offers Rani Therapeutics Holdings Inc stock information, including NASDAQ: RANI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RANI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RANI stock methods without spending real money on the virtual paper trading platform.